The role of low-dose pramipexole in the treatment of treatment-resistant bipolar depression: A case report

Turk Psikiyatri Dergisi

Volumn 20, Issue 1, 2009, Pages 94-98

  Akdeniz, Fisun ^a   Aldemir, Ebru ^a   Vahip, Simavi ^a  

^a NONE

Author keywords

Bipolar disorder; Depressive episode; Pramipexole; Treatment resistant

Indexed keywords

ANTIDEPRESSANT AGENT; BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOL;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; BENZOTHIAZOLES; BIPOLAR DISORDER; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 70049087357     PISSN: 13002163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bennett JP, Piercey MF (1999) Pramipexole - a new dopamine agonist for the treatment of Parkinson's disease. J Neurol Sci, 163: 25-31.
2. Black KJ, Hershey T, Koller JM ve ark. (2002) A possible substrate for dopamine-related changes inmoodand behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci USA, 99:17113-17118.
3. Carvey PM, McGuire SO, Ling ZD (2001) Neuroprotective effects of D3 dopamine receptor agonists. Parkinsonism Relat Disord, 7:213-223.
4. Corrigan MH, Denahan AQ, Wright CE ve ark. (2000) Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety, 11:58-65.
5. DeBattista C, Solvason HB, Breen JA ve ark. (2000) Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. J Clin Psychopharmacol, 20:274-275.
6. Drevets WC (2001) Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol, 11:240-249.
7. Goldberg JF, Frye MA, Dunn RT (1999) Pramipexole in refractory bipolar depression (letter). Am J Psychiatry, 156:798.
8. Goldberg JF, Burdick KE, Endick CJ (2004) Preliminary randomized, doubleblind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry, 161:564-566.
9. Gupta S, Vincent JL, Frank B (2006) Pramipexole: augmentation in the treatment of depressive symptoms. CNS Spectr, 11(3): 172-175.
10. Hubble JP (2000) Pre-clinical studies of pramipexole: clinical relevance. Eur J Neurology, 7 (suppl 1):15-20.
11. Judd LL, Akiskal HS, Schettler PJ ve ark. (2005) Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry, 62(12):1322-1330.
12. Lattanzi L, Dell'Osso L, Cassano P ve ark. (2002) Pramipexole in treatment-resistant depression: a 16-week naturalistic study. Bipolar Disord, 4:307-314
13. Le WD, Jankovic J (2001) Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Aging, 18:389-396
14. Mayberg HS, Brannan SK, Tekell JL ve ark. (2000) Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol Psychiatry, 48:830-843.
15. Perugi G, Toni C, Ruffolo G ve ark. (2001) Adjunctive dopamine agonists in treatment-resistant bipolar II depression: An open case series. Pharmacopsychiatry, 34:137-141.
16. Piercey MF (1998) Pharmacology of pramipexole, a dopamine D3-preferring agonist, useful in treating Parkinson's disease. Clin Neuropharmacol, 21:141-151.
17. Sharma V, Smith A (2007) A case of mania following the use of pramipexole. Am J Psychiatry, 164(2): 351.
18. Singh A, Althoff R, Martineau RJ ve ark. (2005) Pramipexole, ropinirole, and mania in Parkinson's disease. Am J Psychiatry, 162: 814-815.
19. Sporn J, Ghaemi SN, Sambur MR ve ark. (2000) Pramipexole augmentation in the treatment of unipolar and bipolar depression: A retrospective chart review. Ann Clin Psychiatry, 12:137-140.
20. Vahip S (2003) Depresyon dönemi saǧalti{dotless}mi{dotless}. İki Uçlu Duygudurum Bozukluklari{dotless} Saǧalti{dotless}m Ki{dotless}lavuzu'nda. Vahip S ve Yazi{dotless}ci{dotless} O (ed). Türkiye Psikiyatri Derneǧi Yayi{dotless}nlari{dotless}, İstanbul, s: 53-74.
21. Whiskey E, Taylor D (2004) Pramipexole in unipolar and bipolar depression. Psychiatric Bulletin, 28, 438-440.
22. Zarate CA, Payne JL, Singh J ve ark. (2004) Pramipexole for bipolar II depression: A placebo-controlled proof of concept study. Biol Psychiatry, 56, 54-60.